How profitable is Ultralife Corporation (ULBI)?

In FY 2025 (10-K), ULBI converted $191.2M of revenue into a 24.1% gross margin, 0% operating margin, and $7.1M in free cash flow (3.7% FCF margin).

Stock Ratings / Industrials / ULBI / financials

ELVA (44) CHPT (37) AZ (51) QSI (41) ⌘ Pro Terminal →

Ultralife Corporation (ULBI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$15.62 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $15.59

Ultralife Corporation (ULBI) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D+ • SELL / AVOID Cap $260.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ULBI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ULBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Ultralife Corporation (NASDAQ: ULBI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $15.62 (0.00% 1D, market cap $260.3M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 10/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 7/20. Across 486 tracked Industrials issuers, ULBI ranks #167 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ULBI compare to ELVA and CHPT in the Industrials sector?

▼

Within the Industrials sector (Industrial Machinery/Components), ULBI carries a Roarable D+ (56/100 RQD), trailing P/E of N/A, gross margin of 24.1%, and ROIC of -2.8%. By comparison, ELVA (Electrovaya Inc.) holds a D grade (44/100 RQD, P/E N/A, ROIC —, cap $263.5M) and CHPT (ChargePoint Holdings Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $265.3M). Among the 5-stock peer group, ULBI leads on earnings multiple (N/A) while ULBI leads on capital efficiency (-2.8% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ULBI?

▼

Per ULBI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000875657), Ultralife Corporation generated $191.2M in revenue (+16.2% YoY), -$5.9M in net income, and $7.1M in free cash flow against $216.9M in total assets and $45.5M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $15.59 (-0.19%)🧬 Disciplined Float (+0.16% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 3.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY • 51.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

Quant Analyst Panel Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-0.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ULBI)Realized 20D OHLCV Swing Band: ±6.7%

Deterministic 5-Pillar Attribution (56/100 Composite)

🔍 WHY ULBI SCORES 56/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+15/20 pts (27% of score)

20D Institutional Volume Accumulation (±6.7% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+13/20 pts (23% of score)

FRED Regime × Technicals: 99% of 52W Range • RSI-14 at 92 (OVERBOUGHT (>70))

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution7/20 pts (-13 pt drag)

Disciplined Float (+0.16% YoY Shares) & executive Form 4 sales trim 13 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$6.05+2.6% Next Q

Q2 (-2Q)

Grade C-$6.21+151.4% Next Q

Q3 (-1Q)

Grade C-$15.61+0.1% Next Q

Current

Grade D+$15.62-0.4% Hist 90D α

Trajectory: D (48) → D+ (56)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ULBI Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 56/100 (D+) score, ULBI faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($7.24) or 200D SMA ($6.60) invalidates the momentum regime and cuts Target Base ($15.48) toward Bear Floor ($12.07).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ULBI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ULBI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 56%NO 44%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How ULBI Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$7.1M (3.7% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $158.6M

FY24

Rev $164.5M

FY25

Rev $191.2M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$191.2M	24.1%	-3.1%	-$5.9M	$7.1M	-2.8%
FY 2024	$164.5M	25.7%	6.1%	$6.3M	$14.7M	4.4%
FY 2023	$158.6M	24.1%	6%	$7.2M	$1.9M	-2.8%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ULBI)

✓Walkthrough of ULBI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ULBI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +128.70%⚡ TESTING RESISTANCE

2026-11-04O $15.62H $15.62L $15.62C $15.62VOL 248.4K

RES: $16.03SUP: $5.70SMA50: $7.24SMA200: $6.60

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ULBI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ULBI Butterfly Map → + Track ULBI →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +16.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on ULBI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ULBI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ULBI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ULBI)

Industrials Rank #167 of 486 ⚔️ ELVA vs ULBI Full Matrix →

1. Head-to-Head Industrials Peer Comparison (ULBI vs. ELVA, CHPT, AZ, QSI)

Industry: Industrial Machinery/Components (208 Tracked Issuers)

Across 486 tracked Industrials securities in the Roarable RQD universe, Ultralife Corporation (ULBI) ranks #167 by composite RQD confidence (56/100, grade D+) and #336 by equity capitalization ($260.3M). Within this direct 5-issuer industry benchmark cohort, ULBI leads on earnings valuation at N/A trailing P/E, while ULBI leads on capital efficiency and profitability with -2.8% ROIC and 24.1% gross margin. ULBI currently leads its immediate peer cohort in composite quantitative strength at 56/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ULBI ACTIVE Ultralife Corporation	D+	56/100	—	24.1%	-2.8%	0.00%	$260.3M	Benchmark Subject
ELVA Electrovaya Inc.	D	44/100	—	—	—	-0.19%	$263.5M	/elva-vs-ulbi →
CHPT ChargePoint Holdings Inc.	D-	37/100	—	30.5%	-35.0%	+3.56%	$265.3M	/chpt-vs-ulbi →
AZ A2Z Cust2Mate Solutions Corp.	D	51/100	—	—	—	-0.16%	$274.5M	/az-vs-ulbi →
QSI Quantum-Si Incorporated (Class A)	D-	41/100	—	47.3%	-35.0%	-13.70%	$275.8M	/qsi-vs-ulbi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000875657 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Ultralife Corporation (ULBI) reported GAAP revenue of $191.2M (+16.2% vs. FY2024 revenue of $164.5M , and +20.5% cumulative change since FY2023) , GAAP net income of -$5.9M, operating cash flow of $11.0M, and free cash flow of $7.1M (-51.6% YoY). On the balance sheet, ULBI closed FY2025 with $216.9M in total assets against $45.5M in total debt (Altman Z-Score: 2.71, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$191.2M	-$5.9M	$11.0M	$7.1M	$216.9M	$45.5M
FY2024 (FY)	2024-12-31	$164.5M	$6.3M	$16.6M	$14.7M	$220.5M	$51.5M
FY2023 (FY)	2023-12-31	$158.6M	$7.2M	$1.9M	$1.9M	—	—

3. ULBI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ULBI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ULBI compare to ELVA and CHPT in the Industrials sector?

What are the biggest fundamental strengths and SEC risk factors for ULBI?

Where is ULBI trading relative to its 50-day, 200-day, and 52-week technical levels?

ULBI last traded at $15.62 (0.00% on volume of 248,411 shares), positioning the stock +115.75% above its 50-day simple moving average ($7.24) and +136.67% above its 200-day simple moving average ($6.60). Across its 52-week range of $4.90 to $15.67, ULBI sits at the 99.5% percentile with a 14-day RSI of 93.4 (OVERBOUGHT (>70)) and an implied next-earnings move of ±6.7% ($14.57 to $16.67).

Direct Sub-Reports: ULBI RQD Cockpit ULBI 12M Forecast ULBI Earnings & Move ULBI Dividends & DRIP ULBI Insiders & 13F ULBI Whale Options ULBI Profit Sankey ULBI News & Why

ROARABLE RATING BRIEF • RQD 56/100 (D+) ✓ SEC XBRL & RQD VERIFIED

ULBI — Ultralife Corporation: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Ultralife Corporation (ULBI) earns a live Roarable RQD composite score of 56/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $15.62 (0.00% 1D, market capitalization $260.3M).

Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of -2.8%, gross margin of 24.1%, operating margin of -3.1%, and free cash flow yield of 2.73%.
Whale 13F & Options Flow (15/20) + Insider Conviction (7/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (13/20) + Forensic Balance Sheet (10/20): Incorporates a 1.00x equity beta, Altman Z-Score of 2.71, Piotroski F-Score of 6/9, and Debt/Equity of 0.35x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Ultralife Corporation (ULBI) is a NASDAQ-listed issuer classified in the Industrials sector and the Industrial Machinery/Components industry. The company's market capitalization is listed at $0.3B in the profile.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Ultralife Corporation (ULBI) reported $191.2M in annual revenue (up from $164.5M in FY2024, +16.2% YoY) and -$5.9M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($158.6M revenue, $7.2M net income) through FY2025, ULBI scaled operating cash flow to $11.0M and free cash flow to $7.1M, backed by $216.9M in total assets against $45.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (D+ • RQD 56/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of 2.73% and institutional whale pillar of 15/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $4.90 – $15.67 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -3.1% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Industrial Machinery/Components (Industrials), ULBI carries a macro regime beta of 1.00 and gross margin of 24.1%.

Key Question #1: Can ULBI sustain or expand its -3.1% operating margin and -2.8% ROIC against Industrial Machinery/Components peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $191.2M and free cash flow of $7.1M, how will capital allocation balance growth reinvestment against $45.5M in total debt?
Key Question #3: How sensitive is ULBI's equity valuation to Industrials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

ULBI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Ultralife Corporation (ULBI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ULBI Debate Forum (3) ↓

🟡 MARKET WIRE Moomoo • 1d ago

Ultralife (ULBI) Stock Forum and Discussion

Moomoo report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

Ultralife Corporation Estimates – NASDAQ:ULBI

TradingView report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST GuruFocus • 2d ago

Ultralife Corporation (ULBI) Surges 144% Pre-Market Amid Mixed M

GuruFocus report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Kalkine • 2d ago

Top 5 Stocks for October 28 Pre-Market: Biggest Gainers Led by Ultralife Corporation (NASDAQ:ULBI) at 143.87%

Kalkine report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 2d ago

Holders of about 40.3% back Ultralife (ULBI)'s planned cash takeover.

Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 2d ago

At a 166% premium, EnerSys’ cash offer wins Ultralife (ULBI) board backing.

Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 2d ago

A 40.3% holder signs a tender support agreement for Ultralife (ULBI)'s proposed sale.

Stock Titan report covering Ultralife Corporation (ULBI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ChartMill • 1d ago

US Unusual Volume Stocks: ONEG, CENN, SLGB and INLF in Latest Scan

US unusual-volume stocks include ONEG, CENN, SLGB, INLF and others, with volume compared with 50-day averages and price moves detailed in the latest scan.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ULBI Bull vs. Bear Conversation Board — What's Your Call at $15.62?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ULBI 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $18.59 (+19.0%)

📌 Pinned Debate

Reported EnerSys cash takeover headlines, with a 166% premium and 40.3% holder backing, point to a potential acquisition-driven price c

Don't sleep on ULBI's setup in Industrials. Reported EnerSys cash takeover headlines, with a 166% premium and 40.3% holder backing, point to a potential acquisition-driven price catalyst.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (56/100) backs up the fundamental quality.

CapAlloc_Nerd 🐂 BULL

@SiliconVal_Bull Agree on the RQD 56/100 quality, though with 1.0 beta I'm scaling in with half-size at $15.62 and keeping dry powder in case we test $14.53.

BE BearTrap_Alert RQD DEBATE OPENER • Cycle Peak Watcher 🐻 BEARISH 🎯 Target: $11.87 (-24.0%)

Spot @ $15.62

Negative ROIC of -2.8% and a -3.1% operating margin, with FY 2025 operating income falling to -$5.9M, show weak reported operating retu

Sitting on the sidelines or leaning short ULBI above $15.62. Negative ROIC of -2.8% and a -3.1% operating margin, with FY 2025 operating income falling to -$5.9M, show weak reported operating returns.. Until Fundamental Cash Engine (11/20) and FCF yield (2.73%) inflect higher, upside is capped near $15.67.